
--- Page 1 ---
UUID:60FF0C39-8A92-44AF-BF52-841368174119 TCGA-LN-A4A8-01A-PR Redacted Tel: Fax: Clinical Case Report 1cs-0-3 (For Collection of Cancerous Tissue) CouCin0mo, Squsno all, Nos 8070/3 Sifxr esophsqu, mddlthid C15,4 10[3113 Informed Consent I personally informed this patient that a specimen(s) would be collected to be used for research purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution.' Name of Physician or Study Coordinator signature Date Clinical Information GENERAL INFORMATION Date of Birth (mm/dd/yyyy) Helght  Marital Status Race mFs Temperature Single yMarried Gender izNmE$= Weight  Divorced  Widow Male Blood Pressure   Female 6 Q ccA Heart Rate 12/0 HISTORY OF PRESENT ILLNESS Chief Complaints: Flo uhle e Suallwing ; Joc.al chaneye Symptoms: Tined of Clinical Findings: Performance Scale (Karnofsky Score):  100 Asymptomatic   80-90 Symptomatic but Fully Ambulatory '60-70 Symptomatic, in bed less than 50% of day  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden  20-30 Bed Ridden CURRENT MEDICATIONS Drug Dose Route Freguency Date (mm/dd/yyyy) To / To / 1 To / To / / To

--- Page 2 ---
PAST MEDICAL HISTORY Dlagnosis/Disease/Disorder/Injury Diagnosis Date Treatment Status OB/GYN HISTORY  Menopausal Status Date of First Menses. # of Pregnancies  Pre-menopausal  Peri-Menopausal Date of Last Menses # of Live Births  Post-menopausal Birth Control:  Condom  Oral Contraceptive  iUd  Hormone Replacement Therapy:  Other: SOCIAL HISTORY Environmental Hazards: Occupation: Smoking History Current Status TyPE Packs/day Duratlon When Quit  yes  SONO (yrs) (yt) Alcohol Consumption TYPE Drinks/day Duratlon When Qult Current Status YES ONO 9.clcsI dag (yrs)3mmths ag (yr Drug Use TYPE Freguency Duration When Quit Current Status D yeS ENO (yrs)  (yr) FAMILY MEDICAL HISTORY  Relative Dlagnosis Age of Diagnosis LAB DATA Resuit Date Test  Result Test Date HIV Negative  Positive: CEA  Negative  Positive: Hep B  Negative  Positive: CA 15-3  Negative  Positive: Hep C  Negative  Positive: CA 19-9  Negative  Positive: AFP   Negative  Positive: PSA  Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
DIAGNOSTIC STUDIES Study  Results Date Ultrasound X-Ray CT Atucneuy was foure in tho cesophoqus Endoscopy  MRI Biopsy CLINICAL DIAGNOSIS Preoperative Clinical Diagnosis EhBeqa  Location of Suspected Involved Lymph Nodes Location of Suspected Distant Metastasis Clinical Staging Date of Dlagnosis T2 NO M O Stage: IA Treatment Informationd : SURGICAL TREATMENT. Procedure Date of Procedure resectim sy che oeaepsaas Primary Tumor Organ Detailed Location  Size Qesopsi Fs lumer Middle. Shird 2x 2 x/ cm Extension of Tumor Lymph Nodes Description Location of Lymph Nodes. # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ Detailed Location Size Surgical Staging T2. No. Stage: NEOADJUVENT THERAPY (Chemo, Radiation, Immuno, Hormonal, or Molecular) Drug/Treatment Dose Route Frequency Date (mm/dd/yyy) To To 1 To To To 3

--- Page 4 ---
Pathology Form Specimen Information Collected by: -- Date. 'ime . Date Time Preserved by: - SPECIMEN TYPE (# of samples provided) Paraffin Block Blood/Serum/Plasma Slide Frozen Normal Diseased NormaJ Diseased  Normal Diseased Normal Diseased 2 2 2 2 2 Time to LN2 Time to Formalin Time to LN2 min min min /D PATHOLOGICAL DESCRIPTION Primary Tumor Slze Extenslon of Tumor. Distance to NAT Organ Zimur 2Xx2 x4 cm midelle thire 6 Ceso phd ue. cm Lymph Nodes Locatlon # Examined # Metastasized Distant Metastasis Detailed Location. Size Organ Pathological Staging. pT 2. N c m o Stage: T Notes: 4

--- Page 5 ---
cOnsolIdated DIagnostIc patholOgy form* Microscopic Appearance: Histological pattern: 1. CELL DISTRIBUTION Diffuse + STRUCTURAL PATTERN X) Streaming Mosaic Y Storiform Necrosis Fibrosis  Lymphocytic Infiltration  Palisading Vascular Invasion Cystic Degeneration Clusterized Bleeding Alveolar Formation Myxoid Change Indian File 0Psammoma/Calcification 2. Cellular features: Squamous Adenomatous +  Sarcomatous + Lymphomatous  Squamoid Cell Glandular cell Round Cell + : Large Cell  Spindle Cell  Cell Stratification Fibroblast Keratin Small Cell Secretion Ostcoblast  RS Cell/RS Like Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell Pearl  Gland formation Myoblast Otherwise Specified:  Plasma Cell D75% Dz75Z 2. Cellular Differentiation: Well Moderately Poor K  Nuclear Atypia: Nuclear Appearance Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity Nuclear Grade Histological Diagnosis: Sgnomrs lel lakeinsre 6-Z Comments: Director, Research Pathology Date *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND "ATHOLOGIST STAFF FOR RESEARCH USE ONLY) DISQUALIFI